Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial 2024-01-29 21:00
inQB8 Medical Technologies LLC and Peijia Medical Limited Report Successful First-in-Human (FIH) Implantation of MonarQ Transcatheter Tricuspid Valve Replacement (TTVR) System in The United States of America 2023-12-05 21:00
Peijia Medical Presents Early Clinical Findings of GeminiOne® TEER Device at TCT 2023 2023-10-27 20:00
Peijia Medical Announces 2023 Interim Results 2023-09-01 19:00
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System 2023-08-01 20:00
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System 2022-11-25 16:00
Peijia Medical Announces 2021 Annual Results 2022-04-02 00:06
Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treating AR in the Greater China Region 2022-01-19 20:00
Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology 2021-12-30 19:18
Peijia Medical Announces First Patient Implant in the Clinical Trial of its Third-Generation Transcatheter Aortic Valve System TaurusNXT® 2021-09-14 22:11
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the "Retrievable Era" using TAVR products 2021-06-28 11:15
Peijia Medical's Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization 2021-06-25 00:27
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product 2021-06-10 10:26
Peijia Medical's TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization 2021-04-25 08:53
Peijia Medical Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product 2020-12-08 20:00
1